{
  "id": 19852854,
  "title": "Trial on Statins for Cirrhosis Won't End Debate Anytime Soon",
  "url": "https://urgent.news/2026/11/13/trial-on-statins-for-cirrhosis-wont-end-debate-anytime-soon",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-13T18:21:22.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/aasld/123877"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Statin therapy delivered a statistical near miss at lowering risks of hepatic decompensation and liver cancer in patients with compensated cirrhosis, the phase III SACRED trial showed. In an intention-to-treat analysis, 8.97...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}